Review decisions
Showing 800 results of 2631 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1684955300002
Product Type: Drug
Control Number: 262122
DIN(s): 02535270
Manufacturer: Janssen Inc.
Submission Type: New Drug Submission (New Active Substance) - Notice of Compliance with Conditions
Date Filed / Submission Date: 2022-03-04
Issued / Original Publication Date: 2023-05-09
Decision / Authorization Date: 2023-02-09
Updated Date: 2025-05-09
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00926
Product Type: Drug
Control Number: 255450
Manufacturer: Bristol-Myers Squibb Canada Co.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-08-04
Decision / Authorization Date: 2022-03-03
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1732290566153
Product Type: Drug
Control Number: 261973
Manufacturer: Orimed Pharma Inc.
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2022-03-02
Decision / Authorization Date: 2024-03-21
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00923
Product Type: Drug
Control Number: 250272
DIN(s): 02525569
Manufacturer: Novartis Pharmaceuticals Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-03-10
Decision / Authorization Date: 2022-03-01
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SSR00282
Issued / Original Publication Date: 2022-03-01
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00921
Product Type: Drug
Control Number: 254598
Manufacturer: Medicago Inc.
Submission Type: New Drug Submission (New Active Substance) (COVID-19)
Date Filed / Submission Date: 2021-08-09
Decision / Authorization Date: 2022-02-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00922
Product Type: Drug
Control Number: 248874
DIN(s): 02525542
Manufacturer: Canadian Molecular Imaging Probe Consortium (CanProbe)
Submission Type: New Drug Submission
Date Filed / Submission Date: 2021-03-12
Decision / Authorization Date: 2022-02-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00924
Product Type: Drug
Control Number: 256417
Manufacturer: Dr. Reddys Laboratories
Submission Type: New Drug Submission (New Active Substance) (COVID-19)
Date Filed / Submission Date: 2020-12-18
Decision / Authorization Date: 2022-02-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00931
Product Type: Drug
Control Number: 252195
Manufacturer: Eisai Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-05-03
Decision / Authorization Date: 2022-02-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS00935
Product Type: Drug
Control Number: 252263
Manufacturer: Merck Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2021-05-03
Decision / Authorization Date: 2022-02-24